HDAC9 and Stroke: In addition, the animal handling during behavioral testing in Protocol 1 likely also increased the post-stroke neurogenesis in all groups, thus making it more difficult to demonstrate a statistically significant increase in neurogenesis due to the HDAC inhibitors in Protocol 1.